Viral Manufacturing Moves Toward Suspension Cells
Viral Manufacturing Moves Toward Suspension Cells Source: Rost-9D/Getty Images Research by the U.K.’s Centre for Process Innovation (CPI) has involved scaling up adeno-associated virus (AAV) manufacturing using suspension-based systems from flasks to 200-L bioreactors. “The approach we’ve taken is not unique, but the data we’re generating is valuable because we have done a complete scale-up from start to finish,” explains Philip Probert, PhD, head of technical, biologics at the CPI. Probert, who will be presenting the research at the World Smart Bioprocessing Pharma 4.0 summit next...